Hepatitis E virus seroprevalence among blood donors in Southwest Switzerland

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Kaufmann, Annatina ^a   Kenfak Foguena, Alain ^b   André, Cyril ^b   Canellini, Giorgia ^c   Bürgisser, Philippe ^b   Moradpour, Darius ^b   Darling, Katharine E A ^b   Cavassini, Matthias ^b  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c Service Regional Vaudois de Transfusion Sanguine   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; IMMUNOGLOBULIN G;

ADULT; AGE; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; SEROPREVALENCE; SEX DIFFERENCE; SWITZERLAND; ADOLESCENT; EPIDEMIOLOGY; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED; STATISTICS;

ANIMALIA; HEPATITIS E VIRUS;

ADOLESCENT; ADULT; AGED; BLOOD DONORS; FEMALE; HEPATITIS E VIRUS; HUMANS; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; SWITZERLAND; YOUNG ADULT;

EID: 79959322562     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021150     Document Type: Article

References (26)

1. Khuroo MS, Khuroo MS, (2008) Hepatitis E virus. Curr Opin Infect Dis 21: 539 543.
2. Purcell RH, Emerson SU, (2008) Hepatitis E: an emerging awareness of an old disease. J Hepatol 48: 494-503.
3. Okamoto H, (2007) Genetic variability and evolution of hepatitis E virus. Virus Res 127: 216-228.
4. Christensen PB, Engle RE, Hjort C, Homburg KM, Vach W, et al. (2008) Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark. Clin Infect Dis 47: 1026-1031.
5. Dalton HR, Stableforth W, Thurairajah P, Hazeldine S, Remnarace R, et al. (2008) Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. Eur J Gastroenterol Hepatol 20: 784-790.
6. Ijaz S, Arnold E, Banks M, Bendall RP, Cramp ME, et al. (2005) Non-travel-associated hepatitis E in England and Wales: demographic, clinical, and molecular epidemiological characteristics. J Infect Dis 192: 1166-1172.
7. Mansuy JM, Legrand-Abravanel F, Calot JP, Peron JM, Alric L, et al. (2008) High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France. J Med Virol 80: 289-293.
8. Meng XJ, Wiseman B, Elvinger F, Guenette DK, Toth TE, et al. (2002) Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol 40: 117-122.
9. Bouwknegt M, Lodder-Verschoor F, van der Poel WH, Rutjes SA, de Roda Husman AM, (2007) Hepatitis E virus RNA in commercial porcine livers in The Netherlands. J Food Prot 70: 2889-2895.
10. Lewis HC, Wichmann O, Duizer E, (2010) Transmission routes and risk factors for autochthonous hepatitis E virus infection in Europe: a systematic review. Epidemiol Infect 138: 145-166.
11. Kumar A, Aggarwal R, Naik SR, Saraswat V, Ghoshal UC, et al. (2004) Hepatitis E virus is responsible for decompensation of chronic liver disease in an endemic region. Indian J Gastroenterol 23: 59-62.
12. Ollier L, Tieulie N, Sanderson F, Heudier P, Giordanengo V, et al. (2009) Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. Ann Intern Med 150: 430-431.
13. Kenfak Foguena A, Schöni-Affolter F, Bürgisser P, Kovari H, Evison JM, et al. (2010) Hepatitis E Virus Sero-prevalence and Chronic Infection in HIV Patients with Unexplained ALT Elevations: The Swiss HIV Cohort Study. Emerg Infect Dis In press.
14. Kamar N, Selves J, Mansuy JM, Ouezzani L, Peron JM, et al. (2008) Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 358: 811-817.
15. Lavanchy D, Morel B, Frei PC, (1994) Seroprevalence of hepatitis E virus in Switzerland. Lancet 344: 747-748.
16. Herremans M, Bakker J, Duizer E, Vennema H, Koopmans MP, (2007) Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity. Clin Vaccine Immunol 14: 562-568.
17. Boutrouille A, Bakkali-Kassimi L, Cruciere C, Pavio N, (2007) Prevalence of anti-hepatitis E virus antibodies in French blood donors. J Clin Microbiol 45: 2009-2010.
18. Zanetti AR, Dawson GJ, (1994) Hepatitis type E in Italy: a seroepidemiological survey. Study Group of Hepatitis E. J Med Virol 42: 318-320.
19. Bendall R, Ellis V, Ijaz S, Ali R, Dalton H, (2010) A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol 82: 799-805.
20. Ijaz S, (2009) Indigenous hepatitis E virus infection in England: more common than it seems. J Clin Virol 44: 272-276.
21. Kuniholm MH, Purcell RH, McQuillan GM, Engle RE, Wasley A, et al. (2009) Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994. J Infect Dis 200: 48-56.
22. Jameel S, (1999) Molecular biology and pathogenesis of hepatitis E virus. Expert Rev Mol Med 1999: 1-16.
23. Zaaijer HL, Kok M, Lelie PN, Timmerman RJ, Chau K, et al. (1993) Hepatitis E in The Netherlands: imported and endemic. Lancet 341: 826.
24. Mateos ML, Camarero C, Lasa E, Teruel JL, Mir N, et al. (1998) Hepatitis E virus: relevance in blood donors and other risk groups. Vox Sang 75: 267-269.
25. Dalekos GN, Zervou E, Elisaf M, Germanos N, Galanakis E, et al. (1998) Antibodies to hepatitis E virus among several populations in Greece: increased prevalence in an hemodialysis unit. Transfusion 38: 589-595.
26. Dalton HR, Stableforth W, Hazeldine S, Thurairajah P, Ramnarace R, (2008) Autochthonous hepatitis E in Southwest England: a comparison with hepatitis A. Eur J Clin Microbiol Infect Dis 27: 579-585.